Functional neuroimaging of sleep disorders

Current Pharmaceutical Design

Volumn 14, Issue 32, 2008, Pages 3417-3429

  Nofzinger, Eric A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Functional neuroimaging; Sleep disorders

Indexed keywords

AMFEBUTAMONE; ANTIHISTAMINIC AGENT; DOPAMINE; MODAFINIL; PLACEBO; TRIAZOLAM; ZOLPIDEM;

ALERTNESS; ANESTHESIA; BEHAVIOR DISORDER; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN PERFUSION; CLINICAL TRIAL; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG RECEPTOR BINDING; ELECTROENCEPHALOGRAPHY; FATAL FAMILIAL INSOMNIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE METABOLISM; HUMAN; HYPERSOMNIA; HYPOVENTILATION; INSOMNIA; MOTOR DYSFUNCTION; NARCOLEPSY; NEUROIMAGING; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP WAKING CYCLE; SLEEP WALKING; BRAIN; DIAGNOSTIC IMAGING; METHODOLOGY;

BRAIN; DIAGNOSTIC IMAGING; HUMANS; SLEEP DISORDERS;

EID: 58949104345     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786549371     Document Type: Review

References (142)

1. Maquet P, Dive D, Salmon E, Sadzot B, Franco G, Poirrier R, et al. Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18F]2-fluoro-2- deoxy- D-glucose method. Brain Res 1990; 513(1): 136-43.
2. Madsen PL, Holm S, Vorstrup S, Friberg L, Lassen NA, Wildschiodtz G. Human regional cerebral blood flow during rapideye- movement sleep. J Cereb Blood Flow Metab 1991; 11(3): 502-7.
3. Maquet P, Peters J, Aerts J, Delfiore G, Degueldre C, Luxen A, et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 1996; 383(6596): 163-6.
4. Meyer JS, Hayman LA, Amano T, Nakajima S, Shaw T, Lauzon P, et al. Mapping local blood flow of human brain by CT scanning during stable xenon inhalation. Stroke 1981; 12(4): 426-36.
5. Heiss WD, Pawlik G, Herholz K, Wagner R, Wienhard K. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Brain Res 1985; 327(1-2): 362-6.
6. Buchsbaum MS, Gillin JC, Wu J, Hazlett E, Sicotte N, DuPont RM, et al. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci 1989; 45(15): 1349-56.
7. Maquet P, Dive D, Salmon E, Sadzot B, Franco G, Poirrier R, et al. Cerebral glucose utilization during stage 2 sleep in man. Brain Res 1992; 571(1): 149-53.
8. Hofle N, Paus T, Reutens D, Fiset P, Gotman J, Evans AC, et al. Regional cerebral blood flow changes as a function of delta and spindle activity during slow wave sleep in humans. J Neurosci 1997; 17(12): 4800-8.
9. Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 1997; 120(Pt 7): 1173-97.
10. Maquet P. Positron emission tomography studies of sleep and sleep disorders. [Review] [46 refs]. J Neurol 1997; 244(4 Suppl 1): S23-S28.
11. Maquet P, Phillips C. Functional brain imaging of human sleep. J Sleep Res 1998; 7(Suppl 1): 42-7.
12. Maquet P. Brain mechanisms of sleep: Contribution of neuroimaging techniques. J Psychopharmcol 1999; 13(4 Suppl 1): S25-S28.
13. Maquet P. Functional neuroimaging of normal human sleep by positron emission tomography. J Sleep Res 2000; 9(3): 207-31.
14. Nofzinger EA, Mintun MA, Wiseman MB, Kupfer DJ, Moore RY. Forebrain activation in REM sleep: An FDG PET study. Brain Res 1997; 770: 192-201.
15. Nofzinger EA, Mintun MA, Price J, Meltzer CC, Townsend D, Buysse DJ, et al. A method for the assessment of the functional neuroanatomy of human sleep using FDG PET. Brain Res Protocols 1998; 2: 191-8.
16. Nofzinger EA, Buysse DJ, Miewald JM, Meltzer CC, Price JC, Sembrat RC, et al. Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain 2002; 125: 1105-15.
17. Kjaer TW, Law I, Wiltschiotz G, Paulson OB, Madsen PL. Regional cerebral blood flow during light sleep-a H (2) (15) O-PET study. Sleep Res 2002; 11(3): 201-7.
18. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Hazlett E, Sicotte N, et al. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep 1991; 14(2): 155-62.
19. Thomas M, Sing H, Belenky G, Holcomb H, Mayberg H, Dannals R, et al. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res 2000; 9(4): 335-52.
20. Thomas ML, Sing HC, Belenky G, Holcomb HH, Mayberg HS, Dannals RF, et al. Neural basis of alertness and cognitive performance impairments during sleepiness II. Effects of 48 and 72 h of sleep deprivation on waking human regional brain activity. Thalamus Related Syst 2003; 2: 199-229.
21. Paus T, Jech R, Thompson CJ, Comeau R, Peters T, Evans AC. Transcranial magnetic stimulation during positron emission tomography: A new method for studying connectivity of the human cerebral cortex. J Neurosci 1997; 17(9): 3178-84.
22. Paus T, Koski L, Caramanos Z, Westbury C. Regional differences in the effects of task difficulty and motor output on blood flow response in the human anterior cingulate cortex: A review of 107 PET activation studies. Neuroreport 1998; 9(9): R37-R47.
23. Fiset P, Paus T, Daloze T, Plourde G, Meuret P, Bonhomme V, et al. Brain mechanisms of propofol-induced loss of consciousness in humans: A positron emission tomographic study. J Neurosci 1999; 19(13): 5506-13
24. Alkire MT, Haier RJ, Fallon JH. Toward a unified theory of narcosis: brain imaging evidence for a thalamocortical switch as the neurophysiologic basis of anesthetic-induced unconsciousness. Consciousness Cognit 2000; 9(3): 370-86.
25. Mu Q, Nahas Z, Johnson KA, Yamanaka K, Mishory A, Koola J et al. Decreased cortical response to verbal working memory following sleep deprivation. Sleep 2005; 28(1): 55-67.
26. Mu Q, Mishory A, Johnson KA, Nahas Z, Kozel FA, Yamanaka K, et al. Decreased brain activation during a working memory task at rested baseline is associated with vulnerability to sleep deprivation. Sleep 2005; 28(4): 433-46.
27. Drummond SP, Brown GG, Salamat JS, Gillin JC. Increasing task difficulty facilitates the cerebral compensatory response to total sleep deprivation. Sleep 2004; 27(3): 445-51.
28. Chee MW, Choo WC. Functional imaging of working memory after 24 hr of total sleep deprivation. J Neurosci 2004; 24(19): 4560-7.
29. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17): 1203-5.
30. Young T, Hutton R, Finn L, Badr S, Palta M. The gender bias in sleep apnea diagnosis. Are women missed because they have different symptoms? Arch Intern Med 1996; 156(21): 2445-51.
31. Stoohs RA, Bingham L, Ito A, Guilleminault C, Dement WC. Sleep and sleep-disordered breathing in commercial long-haul truck drivers. Cjest 1995; 107: 1275-82.
32. Sanders MH. An update on the sleep heart health study. 1998; Toronto, Canada: American College of Chest Physicians; 1998.
33. Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing. Health outcomes. Am J Respir Crit Care Med 1995; 152(2): 717-20.
34. Partinen M. Stress and the heart: The sleep factor. Stress Medicine 1988; 4: 253-363.
35. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994; 120(5): 382-8.
36. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97(1): 27-32.
37. Bedard MA, Montplaisir J, Richer F, Rouleau I, Malo J. Obstructive sleep apnea syndrome: Pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol 1991; 13(6): 950-64.
38. Berry DT, Webb WB, Block AJ, Bauer RM. Nocturnal hypoxemia and neuropsychologic variable. J Clin Exp Neuropsychol 1986; 8: 229-38.
39. Bonnet MH. Cognitive effects of sleep and sleep fragmentation. Sleep 1993; 16(8 Suppl): S65-7.
40. Cheshire K, Engleman H, Deary I, Shapiro C, Douglas NJ. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med 1992; 152(3): 538-41.
41. George CFP, Boudreau AC, Smiley A. Simulated driving performance in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154: 175-81.
42. Findley L, Unverzagt M, Guchu R, Fabrizio M, Buckner J, Suratt P. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest 1995; 108(3): 619-24.
43. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population- based sample of employed adults. Sleep 1997; 20(8): 608-13.
44. Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002; 11(1): 1-16.
45. Naegele B, Thouvard V, Pepin JL, Levy P, Bonnet C, Perret JE, et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 1995; 18(1): 43-52.
46. Redline S, Tishler PV, Hans MG, Tosteson TD, Strohl KP, Spry K. Racial differences in sleep-disordered breathing in AfricanAmericans and Caucasians [published erratum appears in Am J Respir Crit Care Med 1997 May; 155(5): 1820]. Am J Respir Crit Care Med 1997; 155(1): 186-92.
47. Kotterba S, Rasche K, Widdig W, Duscha C, Blombach S, Schultze-Werninghaus G, et al. Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy. J Neurol Sci 1998; 159(1): 45-50.
48. Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987; 10(3): 254-62.
49. Harrison Y, Horne JA, Rothwell A. Prefrontal neuropsychological effects of sleep deprivation in young adults - a model for healthy aging? Sleep 2000; 23(8): 1067-73.
50. Carskadon MA, Bearpark HM, Sharkey KM, Millman RP, Rosenberg C, Cavallo A, et al. Effects of menopause and nasal occlusion on breathing during sleep. Am J Respir Crit Care Med 1997; 155(1): 205-10.
51. Bedard MA, Montplaisir J, Malo J, Richer F, Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol 1993; 15(2): 330-41.
52. Feuerstein C, Naegele B, Pepin JL, Levy P. Frontal lobe-related cognitive functions in patients with sleep apnea syndrome before and after treatment. Acta Neurol Belg 1997; 97(2): 96-107.
53. Borbely AA. From slow waves to sleep homeostasis: New perspectives. Arch Ital Biol 2001; 139(1-2): 53-61.
54. Benington JH, Heller HC. Restoratin of brain energy-metabolism as the function of sleep. Prog Neurobiol 1995; 45(4): 347-60.
55. De Gennaro L, Ferrara M, Curcio G, Cristiani R. Antero-posterior EEG changes during the wakefulness-sleep transition. Clin Neurophysiol 2001; 112(10): 1901-11.
56. Finelli LA, Achermann P, Borbely AA. Individual 'Fingerprints' in human sleep EEG topography. Neuropsychopharmacology 2001; 25(5 Suppl 1): S57-S62.
57. Cajochen C, Knoblauch V, Krauchi K, Renz C, Wirz-Justice A. Dynamics of frontal EEG activity, sleepiness and body temperature under high and low sleep pressure. Neuroreport 2001; 12(10): 2277-81.
58. Kingshott RN, Cosway RJ, Deary IJ, Douglas NJ. The effect of sleep fragmentation on cognitive processing using computerized topographic brain mapping. J Sleep Res 2000; 9(4): 353-7.
59. Finelli LA, Borbely AA, Achermann P. Functional topography of the human nonREM sleep electroencephalogram. Eur J Neurosci 2001; 13(12): 2282-90.
60. Cajochen C, Foy R, Dijk D-J. Frontal predominance of a relative increase in sleep delta and theta EEG activity after sleep loss in humans. Sleep Res Online 1999; 2(3): 65-9.
61. Harrison Y, Horne JA. The impact of sleep deprivation on decision making: A review. J Exp Psychol Appl 2000; 6(3): 236-49.
62. Horne J. Neuroscience. Images of lost sleep [news; comment]. Nature 2000; 403(6770): 605-6.
63. Ficker JH, Feistel H, Moller C, Merkl M, Dertinger S, Siegfried W, et al. Changes in regional CNS perfusion in obstructive sleep apnea syndrome: Initial SPECT studies with injected nocturnal 99mTc-HMPAO. Pneumologia 1997; 51(9): 926-30.
64. O'Donoghue FJ, Briellmann RS, Rochford PD, Abbott DF, Pell GS, Chan CH et al. Cerebral structural changes in severe obstructive sleep apnea. Am J Respir Crit Care Med 2005; 171(10): 1185-90.
65. Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, Corfield DR. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med 2003; 4(5): 451-4.
66. Ding J, Nieto FJ, Beauchamp NJ, Harris TB, Robbins JA, Hetmanski JB, et al. Sleep-disordered breathing and white matter disease in the brainstem in older adults. Sleep 2004; 27(3): 474-9.
67. Kumar R, Macey PM, Woo MA, Alger JR, Keens TG, Harper RM. Neuroanatomic deficits in congenital central hypoventilation syndrome. J Comp Neurol 2005; 487(4): 361-71.
68. Harper RM, Macey PM, Woo MA, Macey KE, Keens TG, Gozal D, et al. Hypercapnic exposure in congenital central hypoventilation syndrome reveals CNS respiratory control mechanisms. J Neurophysiol 2005; 93(3): 1647-58.
69. Macey KE, Macey PM, Woo MA, Harper RK, Alger JR, Keens TG, et al. fMRI signal changes in response to forced expiratory loading in congenital central hypoventilation syndrome. J Appl Physiol 2004; 97(5): 1897-907.
70. Macey KE, Macey PM, Woo MA, Henderson LA, Frysinger RC, Harper RK, et al. Inspiratory loading elicits aberrant fMRI signal changes in obstructive sleep apnea. Respir Physiol Neurobiol 2005.
71. Macey PM, Macey KE, Henderson LA, Alger JR, Frysinger RC, Woo MA, et al. Functional magnetic resonance imaging responses to expiratory loading in obstructive sleep apnea. Respir Physiol Neurobiol 2003; 138(2-3): 275-90.
72. Macey PM, Macey KE, Woo MA, Keens TG, Harper RM. Aberrant neural responses to cold pressor challenges in congenital central hypoventilation syndrome. Pediatr Res 2005; 57(4): 500-9.
73. Macey PM, Woo MA, Macey KE, Keens TG, Saeed MM, Alger JR, et al. Hypoxia reveals posterior thalamic, cerebellar, midbrain, and limbic deficits in congenital central hypoventilation syndrome. J Appl Physiol 2005; 98(3): 958-69.
74. Woo MA, Macey PM, Macey KE, Keens TG, Woo MS, Harper RK, et al. FMRI responses to hyperoxia in congenital central hypoventilation syndrome. Pediatr Res 2005; 57(4): 510-8.
75. Thomas RJ, Rosen BR, Stern CE, Weiss JW, Kwong KK. Functional imaging of working memory in obstructive sleep-disordered breathing. J Appl Physiol 2005; 98(6): 2226-34.
76. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene [see comments]. Cell 1999; 98(3): 365-76.
77. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation [see comments]. Cell 1999; 98(4): 437-51.
78. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy [letter]. Lancet 2000; 355(9197): 39-40.
79. Hublin C, Launes J, Nikkinen P, Partinen M. Dopamine D2-receptors in human narcolepsy: A SPECT study with 123I-IBZM. Acta Neurol Scand 1994; 90(3): 186-9.
80. Asenbaum S, Zeithofer J, Saletu B, Frey R, Brucke T, Podreka I, et al. Technetium-99m-HMPAO SPECT imaging of cerebral blood flow during REM sleep in narcoleptics. J Nucl Med 1995; 36(7): 1150-5.
81. Sudo Y, Suhara T, Honda Y, Nakajima T, Okubo Y, Suzuki K, et al. Muscarinic Cholinergic receptors in human narcolepsy: A PET study. Neurology 1998; 51(5): 1297-302.
82. Joo EY, Tae WS, Kim JH, Kim BT, Hong SB. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol 2004; 56(3): 437-40.
83. Joo EY, Hong SB, Tae WS, Kim JH, Han SJ, Cho YW, et al. Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage 2005; 28(2): 410-6.
84. Hong SB, Tae WS, Joo EY. Cerebral perfusion changes during cataplexy in narcolepsy patients. Neurology 2006; 66(11): 1747-9.
85. Joo EY, Seo DW, Tae WS, Hong SB. Effect of modafinil on cerebral blood flow in narcolepsy patients. Sleep 2008; 31(6): 868-73.
86. Brenneis C, Brandauer E, Frauscher B, Schocke M, Trieb T, Poewe W, et al. Voxel-based morphometry in narcolepsy. Sleep Med 2005.
87. Eisensehr I, Linke R, Tatsch K, von Lindeiner H, Kharraz B, Gildehaus FJ, et al. Alteration of the striatal dopaminergic system in human narcolepsy. Neurology 2003; 60(11): 1817-9.
88. Nose I, Ookawa T, Tanaka J, Yamamoto T, Uchimura N, Maeda H, et al. Decreased blood flow of the left thalamus during somnolent episodes in a case of recurrent hypersomnia. Psychiatry Clin Neurosci 2002; 56(3): 277-8.
89. Smith MT, Perlis ML, Chengazi VU, Pennington J, Soeffing J, Ryan JM, et al. Neuroimaging of NREM sleep in primary insomnia: A Tc-99-HMPAO single photon emission computed tomography study. Sleep 2002; 25(3): 325-35.
90. Nofzinger EA, Price JC, Meltzer CC, Buysse DJ, Villemagne VL, Miewald JM, et al. Towards a neurobiology of dysfunctional arousal in depression: The relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res 2000; 98(2): 71-91.
91. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Insomnia: Functional neuroimaging evidence for hyperarousal. Am J Psychiatry. In press 2003.
92. Kajimura N, Nishikawa M, Uchiyama M, Kato M, Watanabe T, Nakajima T, et al. Deactivation by Benzodiazepine of the Basal Forebrain and Amygdala in Normal Humans During Sleep: A Placebo-Placebo-Controlled [(15)OH(2)O PET Study. Am J Psychiatry 2004; 161(4): 748-51.
93. Perani D, Cortelli P, Lucignani G, Montagna P, Tinuper P, Gallassi R, et al. [18F]FDG PET in fatal familial insomnia: The functional effects of thalamic lesions. Neurology 1993; 43(12): 2565-9.
94. Kloppel S, Pirker W, Brucke T, Kovacs GG, Almer G. Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia. Journal of Neural Transmitters 2002; 109(7-8): 1105-10.
95. Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, et al. Changes in forebrain function from waking to REM sleep in depression: Preliminary analyses of [18F] FDG PET studies. Psychiatry Research Neuroimaging 1999; 91(2): 59-78.
96. Nofzinger EA, Berman S, Fasiczka A, Miewald JM, Meltzer CC, Price JC, et al. Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: Preliminary findings using [18F]-FDG PET. Psychiatry Res 2001; 106(2): 95-111.
97. Nofzinger EA, Buysse DJ, Germain A, Carter CS, Luna B, Price JC, et al. Increased activation of anterior paralimbic and executive cortex from waking to REM sleep in depression. Arch Gen Psychiatry. In press 1 A.D.
98. McCarley RW. REM sleep and depression: Common neurobiological control mechanisms. Am J Psychiatry 1982; 139: 565-70.
99. Ho AP, Gillin JC, Buchsbaum MS, Wu JC, Abel L, Bunney WE. Brain glucose metabolism during non-rapid eye movement sleep in major depression: A positron emission tomography study. Arch Gen Psychiatry 1996; 53(7): 645-52.
100. Germain A, Nofzinger EA, Kupfer DJ, Buysse DJ. Neurobiology of NREM sleep in depression: Further evidnece for hypofrontality and thalamic dysregulation. Am J Psychiatry. In press 2004.
101. Nofzinger EA, Buysse DJ, Germain A, Price JC, Meltzer CC, Miewald JM, et al. Alterations in regional cerebral glucose metabolism across waking and non-rapid eye movement sleep in depression. Arch Gen Psychiatry 2005; 62: 387-96.
102. Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: A study with Tc-99m-HMPAO SPECT. Psychiatry Res 1991; 40(4): 247-51.
103. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992; 149(4): 538-43.
104. Ebert D, Feistel H, Kaschka W, Barocka A, Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation - preliminary results. Biol Psychiatry 1994; 35(11): 880-5.
105. Volk SA, Kaendler SH, Hertel A, Maul FD, Manoocheri R, Weber R, et al. Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Res 1997; 75(2): 67-74.
106. Smith GS, Reynolds CF, Pollock B, Derbyshire S, Nofzinger E, Dew MA, et al. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry 1999; 156(5): 683-9.
107. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999; 156(8): 1149-58.
108. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994; 28: 239-65.
109. Werth E, Achermann P, Borbely AA. Fronto-occipital EEG power gradients in human sleep. J Sleep Res 1997; 6(2): 102-12.
110. Weiler MA, Buchsbaum MS, Gillin JC, Tafalla R, Bunney WE. Explorations in the relationship of dream sleep to schizophrenia using positron emission tomography. Neuropsychobiology 1990; 23(3): 109-18.
111. Staedt J, Stoppe G, Kogler A, Munz D, Riemann H, Emrich D, et al. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). Journal of Neural Transmitters Gen Sect 1993; 93(1): 71-4.
112. Staedt J, Stoppe G, Kogler A, Riemann H, Hajak G, Munz DL, et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 1995; 245(1): 8-10.
113. Staedt J, Stoppe G, Kogler A, Riemann H, Hajak G, Munz DL, et al. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). Journal of Neural Transmitters Gen Sect 1995; 99(1-3): 187-93.
114. Michaud M, Soucy JP, Chabli A, Lavinge G, Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 2002; 249(2): 164-70.
115. Tribl GG, Asenbaum S, Happe S, Bonelli RM, Zeitlhofer J, Auff E. Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nucl Med Commun 2004; 25(1): 55-60
116. Eisensehr I, Wetter TC, Linke R, Noachtar S, von Lindeiner H, Gildehaus FJ, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001; 57(7): 1307-9.
117. Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, et al. Support for dopaminergic hypoactivity in restless legs syndrome: A PET study on D2-receptor binding. Brain 2006; 129(8): 2017-28.
118. Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 1997; 41(5): 639-45.
119. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56(2): 263-5.
120. Bassetti C, Vella S, Donati F, Wielepp P, Weder B. SPECT during sleepwalking. Lancet 2000; 356(9228): 484-5.
121. Shirakawa S, Takeuchi N, Uchimura N, Ohyama T, Maeda H, Abe T, et al. Study of image findings in rapid eye movement sleep behavioural disorder. Psychiatry Clin Neurosci 2002; 56(3): 291-2.
122. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000; 123(Pt 6): 1155-60.
123. Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000; 55(9): 1410-2.
124. Gilman S, Koeppe RA, Chervin RD, Consens FB, Little R, An H, et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 2003; 61(1): 29-34.
125. Mazza M, Soucy JP, Gravel P, Michaud M, Postuma R, Massicotte-Marquez J, et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology 2006; 67(9): 1618-22.
126. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003; 26(5): 507-12.
127. Iranzo A, Santamaria J, Pujol J, Moreno A, Deus J, Tolosa E. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder. Sleep 2002; 25(8): 867-70.
128. Caselli RJ, Chen K, Bandy D, Smilovici O, Boeve BF, Osborne D, et al. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep 2006; 29: 927-33.
129. Klunk WE, Engler H, Nordberg A, Bacskai BJ, Wang Y, Price JC, et al. Imaging the pathology of Alzheimer's Disease: Amyloid-imaging with poistron emission tomography. Neuroimaging Clinics of North America 2003; 13(4): 781-9.
130. Bohnen NI, Frey KA. The role of positron emission tomography imaging in movement disorders. Neuroimaging Clinics of North America 2003; 13(4): 791-803.
131. Powers WJ, Zazulia AR. The use of positron emission tomography in cerebrovascular disease. Neuroimaging Clin N Am 2003; 13(4): 741-58
132. Spence AM, Mankoff DA, Muzi M. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 2003; 13(4): 717-39.
133. Juhasz C, Chugani HT. Imaging the epileptic brain with positron emission tomography. Neuroimaging Clinics of North America 2003; 13(4): 705-16
134. Drummond SPA, Smith MT, Orff HJ, Chengazi V, Perlis ML. Functional imaging of the sleeping brain: Review of findings and implications for the study of insomnia. Sleep Medicine Reviews. In press 2004.
135. Nofzinger EA. Advancing the neurobiology of insomnia. A commentary on: Functional imaging of the sleeping brain. Review of findings and implications for the study of insomnia. Sleep Medicine Reviews. In press 2004.
136. Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T, et al. Roles of histamine in regulation of arousal and cognition: Functional neuroimaging of histamine H1 receptors in human brain. Life Sci 2002; 72(4-5): 409-14.
137. Okamura N, Yanai K, Higuchi M, Sakai J, Iwata R, Ido T, et al. Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br J Pharmacol 2000; 129(1): 115-23.
138. Reinsel RA, Veselis RA, Dnistrian AM, Feshchenko VA, Beattie BJ, Duff MR. Midazolam decreases cerebral blood flow in the left prefrontal cortex in a dose-dependent fashion. International Journal of Neuropsychopharmacology 2000; 3(2): 117-27.
139. Gillin JC, Buchsbaum MS, Valladares-Neto DC, Hong CC, Hazlett E, Langer SZ, et al. Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: A positron emission tomography study. Neuropsychopharmacology 1996; 15(3): 302-13.
140. Finelli LA, Landolt HP, Buck A, Roth C, Berthold T, Borbely AA, et al. Functional neuroanatomy of human sleep states after zolpidem and placebo: A H215O-PET study. J Sleep Res 2000; 9(2): 161-73.
141. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Pappas N, Lowrimore P, et al. Depression of thalamic metabolism by lorazepam is associated with sleepiness. Neuropsychopharmacology 1995; 12(2): 123-32.
142. Nofzinger EA, Price JC, Meltzer CC, Buysse DJ, Villemagne VL, Miewald JM, et al. Towards a neurobiology of dysfunctional arousal in depression: The relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res 2000; 98(2): 71-91.